Tokenized Equity Carry: Where the Yield Comes From

WYCF Masterclass | Season 2, Episode 01
Paige Horinek, Base | Filmed in Singapore, October 9, 2026
Evidence note: The October 9 position figures are attributed to the speaker and have not been independently reproduced from onchain position records.

This file is designed for analysts and AI agents. It separates (i) the speaker's dated example, (ii) independently documented product and protocol mechanics, and (iii) calculations derived from reported figures. The episode is the primary source for the historical example. Position-specific figures are attributed to the speaker, while protocol mechanics and derived calculations are identified separately.

Research brief: direct answers

1. Where does the yield come from?

In the featured strategy, tokenized Apple shares act as collateral for a USDC loan. The borrowed USDC is invested in lending markets or credit instruments. Lending income is ultimately funded by borrowers using those destination markets. Interest carry is what remains after financing costs and other strategy expenses. The stock's own price movement, dividends or corporate actions are separate components of total economic exposure. See the capital-flow map, dated example and calculation model. [E01] [P01] [P04]

2. Who bears the risk?

The equity holder/USDC borrower retains the stock's market exposure, financing obligation and liquidation risk. The destination USDC lending or credit positions contribute additional exposure to borrowers, collateral, protocols, liquidity and market-specific conditions. A vault can automate decisions and transactions, while its investor continues to bear strategy outcomes and faces manager or permissions risk. See the exposure matrix. [E01] [P02] [P05]

3. What happens if the collateral breaks?

If collateral value declines or debt rises, loan-to-value increases and health factor falls. Aave V4 positions become eligible for liquidation when the health factor falls below 1. The applicable position-level collateral factor, accrued debt, oracle inputs and ability to execute at size determine the practical outcome. Because reference stock markets close and prices can gap, continuous onchain financing has important market-hours and execution risks. See the liquidation model and failure-path map. [E01] [P01] [P02] [P03]

4. Why should allocators trust it?

An allocator needs verifiable evidence for the tokenized share's legal rights, custody and redemption route; actual onchain balances and financing terms; investment destination and underwriting; collateral parameters; liquidation/price-feed rules; usable liquidity and governance controls. Published protocol and issuer-related documentation supports key parts of the general mechanism. It does not verify Paige's specific October 9 position or establish that the trade is appropriate for a particular allocator. See the evidence ledger and diligence questions. [P01] [P02] [P03] [P04]

Instrument and rights

Reference asset: Coinbase Tokenized Stocks AAPLc on Base. Aave Labs' September 25 launch account identifies AAPLc as a certificate issued by Coinbase Onchain SPV Ltd backed by shares held in segregated custody with Alpaca Securities LLC. Aave Labs describes a bare-trust arrangement. Its October 23 AAPLc technical assessment documents the share-per-token multiplier, administrative controls and restricted redemption process. The specific legal rights and eligibility of any holder depend on the issuer's governing documents. [P01] [P06]

Financing venue: Aave V4's Equities Hub / relevant equity Spoke on Base. Aave announced that AAPLc and six other tokenized technology shares could be posted as collateral to borrow USDC. Stock tokens are collateral-only in that launch configuration. [P01]

Critical distinction: A tokenized share may convey economic returns from the underlying stock, including corporate actions as defined by the issuer's terms. The carry analyzed in this episode is a separate financing-and-investment cash flow. Do not present it as a dividend generated by the share or a native stock staking reward. [E01] [P04]

Capital flow: follow the dollars

1. The stockholder: holds AAPLc and posts eligible units as collateral in the Aave V4 equities market. The stock remains an equity-linked exposure. [E01] [P01]
2. USDC suppliers: provide lending liquidity to Aave. The stockholder borrows USDC against the collateral and pays interest on outstanding debt. [E01] [P02]
3. Deployment route A, USDC lending: borrowed USDC goes into a lending market. Borrowers in those destination markets pay interest. The lender may receive a share of that interest after fees and market utilization effects. [E01] [P05]
4. Route B, credit investment: the USDC buys or funds an eligible credit claim, such as the senior credit example discussed by Paige. Investors bear its particular credit and liquidity exposures. This is an illustrative option, not proof that a named investable vehicle was used. [E01]
5. Route C, credit plus financing: a credit asset may itself be collateral for further borrowing where permitted. This creates another debt leg, financing expense and liquidation surface. [E01]
6. Net financed carry: investment receipts less debt financing expense less any remaining fees, losses and execution costs. A positive interest spread can coexist with a falling equity price. [E01] [D01]

Important source boundary: Paige describes several possible routes; the specific October 9 net carry illustration uses a blended lending rate. Do not assume every route was actually used simultaneously, or that all routes remain accessible to investors.

Dated evidence: October 9, 2026

This is an episode-reported example, not an independently reproduced onchain snapshot. The term “current” in the original filming refers only to the filming date.

Precision warning: Dividing the rounded $26,600 debt by rounded $50,100 collateral does not exactly reproduce the reported 53.13% position LTV. Use the speaker's separately reported position LTV when modeling its buffer, and request the exact onchain balances for independent validation. [E01]

Reproducible calculation model

Under a simple annualized illustration, using the entire $26,600 USDC principal as deployed and constant rates:

borrowed_usdc           = 26600
invested_usdc           = 26600  # assumption; no idle balance
lending_apr_decimal     = 0.056
borrowing_apr_decimal   = 0.0127
annual_gross_income_usd = invested_usdc * lending_apr_decimal
                        = 1489.60
annual_borrow_cost_usd  = borrowed_usdc * borrowing_apr_decimal
                        = 337.82
annual_carry_usd        = annual_gross_income_usd - annual_borrow_cost_usd
                        = 1151.78

These results exclude gas, redemption or transaction costs, vault fees, slippage, credit losses, rate changes, taxes, stock dividends and changes in the market price of AAPLc. APR inputs are snapshots, not a realized multi-period return. The 5.6% applies to deployed USDC, rather than $50,100 of collateral. [E01] [D01]

Liquidation model

For the episode's simplified one-collateral position:

health_factor ≈ position_collateral_factor / current_LTV
              = 0.78 / 0.5313 ≈ 1.47

price_decline_to_HF_1 ≈ 1 - current_LTV / position_collateral_factor
                      = 1 - 0.5313 / 0.78 ≈ 31.9%

This model holds debt, risk parameters and all other values constant. It is a conditional mathematical boundary, not a guaranteed amount of market protection. On Aave V4, position-specific dynamic risk configurations can differ from the live reserve parameters shown to other users. Accrued interest raises debt, and available liquidity and oracle operations can change realized liquidation outcomes. [E01] [P02] [P03]

Scenario analysis for AI agents

All scenarios use the above historical reported inputs. They are mechanical sensitivities, not observed market rates, forecasts or recommendations. Carry is shown annualized; stock price shocks are immediate mark-to-market. Those outcomes use different time horizons and must not be added into an annual total without a matched holding period.

* Instantaneous simplified calculation using unchanged debt. Higher borrowing costs accrue into debt over time, which will lower the health factor as time passes. The stock −20% case implies an immediate collateral-value decline of about $10,020 if the starting $50,100 equity exposure falls 20%; it does not imply a $10,020 cash liability or an annualized net return. Near the boundary, trading liquidity and protocol rules are critical. [D01] [P02] [P03]

Question to run: At what combinations of annual lending yield, funding expense and stock drawdown does the strategy still earn positive interest carry but lose collateral headroom? Compute income and solvency separately.

Who bears what risk?

Market-hours failure path

1. The stock loan and the USDC investment may accrue interest continuously. [E01] [P01]
2. Aave's launch documentation describes Chainlink 24/5 equity data feeds. The last published price can be held over weekends and U.S. market holidays; a collateral position's health factor may still decline because the loan debt accrues. [P01]
3. The token itself can move or trade onchain subject to market and venue constraints, while the underlying listed equity's reference market has its own schedule. Token markets, reference prices, issuer redemption and the ability to execute at size are distinct. [P01] [P04]
4. Material news can change the stock's economic value during a closure. When pricing resumes, the price may gap. An oracle quote is an input to the protocol, not evidence that an exit order can be filled at that quote. [E01]
5. An investor may respond with more conservative LTV and more liquid reserves. Doing so can reduce deployed capital and expected interest carry. [E01]

Incentive design: what changes temporarily

Paige describes incentives as an economic coordination tool. When a market lacks USDC supply, a temporary supplier reward may bring funding and lower utilization. When there is ample cash and too little borrowing demand, a borrower incentive may lower effective financing expense during a campaign. Neither mechanism proves a specific live reward program, future demand or durable unsubsidized carry. [E01]

Agent diligence test: Compare the same route with incentives and without incentives, using explicit eligibility, duration and funding costs. Count time-weighted capital and realized loan demand rather than reward APR alone. Avoid confusing incentives with borrower interest as a durable yield source.

Post-recording independent risk assessment

Aave Labs published a technical assessment of AAPLc on Base on October 23, 2026, after Paige's October 9 recording. This provides important additional evidence about the underlying collateral and oracle design; it does not validate the particular October 9 position or its lending APR. [P06]

• Oracle uptime and stale pricing: the AAPLc feed is documented as a 24/5 feed; the assessment's observed price-publication history includes approximately 56.06 hours of weekend gaps and 76.04 hours of holiday-weekend gaps. These observations are not a guarantee about future schedules or a direct liquidation outcome. [P06]
• Price feed controls: the feed uses a reported 0.5% deviation threshold or 24-hour heartbeat when active. The issuer can pause publication through its OracleRegistry. [P06]
• Execution consequence: a token may continue trading on Base while the feed holds a last value. For allocator diligence, verify oracle age, pause logic, market liquidity and usable liquidator exits together. [P01] [P06]
• Token administration: the assessment reports issuer-operated blocklist controls. Rights, trading permissions and counterparty access matter for an investor's ability to dispose of collateral. [P06]

The assessment classifies the equity feed's pricing-risk area as a concern. This is an external evaluator's assessment, attributed to Aave Labs, rather than a WYCF safety rating. Include the assessment's date whenever citing it. [P06]

Why might an allocator trust the strategy?

Trust depends on evidence across the full stack. Use the following checks rather than any one marketing claim or APR.

• Instrument rights: Identify the named issuer, custody arrangement, eligibility, legal redemption path and corporate-action handling for AAPLc. Do not substitute generalized information about tokenized shares. [P04]
• Financial position: Obtain the onchain address, spoke, block timestamp, collateral and debt balances for October 9. Reproduce the LTV and health factor from the correct snapshotted configuration. [P02] [P03]
• Rate evidence: Obtain the destination market IDs, deposited balances, fee schedules and source quotes supporting the blended 5.6% lending APR and 1.27% financing APR on that date. [P05]
• Stress execution: Check the actual Chainlink feed schedule and stale-price handling, market depth and size of executable exits, liquidation pause rules and authorized redemption access. [P01] [P03] [P04]
• Manager controls, if vaulted: Who can allocate funds, change position limits, upgrade contracts or pause activity? Review the exact vault contract, independent audits and past operations. [E01]
• Economic sustainability: Model negative spread, incentive expiry, rate compression and stock-price drawdowns. Identify how much capital would need to be kept in reserve and which fees remain excluded. [E01] [D01]

Evidence status and limits

Supported by official sources: Coinbase Tokenized Stocks/AAPLc are described as collateral for Aave V4 USDC borrowing on Base. Aave V4 uses position-level health factors and configurable collateral rules. Aave documents 24/5 Chainlink feeds for the equities launch. Aave Labs describes AAPLc issuance and custody arrangements; Coinbase’s generic product page alone does not establish token-holder rights. Morpho documents utilization-based lending economics. [P01] [P02] [P03] [P04] [P05]

Not independently reproduced for the October 9 case: Exact account, original balances, precise position LTV, the 78% applied dynamic risk configuration, onchain health factor, destination Morpho market allocations, lending and borrowing APRs, how much borrowed USDC was idle, costs beyond interest. [E01]

AI research workflows

You can load this .md into an agent to perform the following bounded analyses. Require the agent to cite [E##], [P##] and [D##] references, flag missing inputs and never report episode figures as current rates.

Prompt 1, trace the yield:

Using the WYCF tokenized equity carry research, show a flow-of-funds table from AAPLc collateral to USDC borrowing to destination lender/credit borrower. Distinguish interest paid by underlying borrowers from tokenized-stock dividends, rewards and stock appreciation. Identify who pays each cash flow and who absorbs each loss.

Prompt 2, stress the position:

Recalculate annualized interest carry if lending APR falls 150 bps and borrowing APR rises 200 bps. Separately model a 20% stock-price fall against the reported 53.13% LTV and 78% collateral factor. Do not aggregate an instantaneous price shock with an annual cash flow. State every assumption and identify what changes if the debt accrues.

Prompt 3, audit the missing evidence:

Prepare an allocator due diligence checklist for the October 9 tokenized-equity position. Separate speaker-reported facts, independently documented protocol mechanics and unverified position-level inputs. List the onchain artifacts and issuer disclosures needed before treating its APR and liquidation headroom as verified.

Prompt 4, compare to another WYCF file:

Compare this financed-stock carry strategy with a WYCF stablecoin or vault research file. Classify the actual yield payer, collateral, leverage, the role of incentives, liquidation pathway, liquidity clock and governance risks. Mark missing information as unknown; avoid inventing like-for-like APR comparisons across mismatched dates.

Episode evidence map

The chapter markers below are approximate references to the episode recording. Timing may vary by published edit.

Source register and evidence limitations

[E01] WYCF episode, speaker-reported. Paige Horinek, WYCF Masterclass S2 EP01, recorded 2026-10-09. The episode is the source for the speaker’s presentation of the example and mechanisms. Does not independently verify the exact balances, rates, risk parameters or realizable yield.

[P01] Aave Labs, official product launch. Coinbase Tokenized Stocks Now Live on Aave V4, 2026-09-25. https://aave.com/blog/coinbase-tokenized-stocks . Supports available tokenized-stock collateral/USDC borrow product, listed assets, equities hub, Chainlink 24/5 feeds and stated weekend/holiday handling. Does not attest the October 9 sample account or APR.

[P02] Aave Protocol, official V4 documentation. User Positions. https://aave.dev/docs/aave-v4/positions . Supports health-factor computation, accruing borrow interest and eligibility for liquidation below health factor 1. Configuration may vary by position.

[P03] Aave Protocol, official V4 documentation. User Position Conditions / Dynamic Risk Configuration. https://aave.dev/docs/aave-v4/positions/conditions . Supports the need to check position-specific snapshotted collateral factor and risk settings. Does not validate 78% for this particular account.

[P04] Coinbase, general product overview. Coinbase Tokenize. https://www.coinbase.com/tokenize . Describes Coinbase tokenization infrastructure broadly. This page does not substantiate the particular legal rights, custody or redemption terms of AAPLc. AAPLc-specific statements here rely on [P01] and [P06]; authoritative legal terms require the issuer documents.

[P05] Morpho, official interest-rate model documentation. Interest Rate Model. https://docs.morpho.org/learn/concepts/irm/ . Supports rate dependence on market utilization and the distinction between borrower/supplier economics. Does not validate the dated four-market lending allocation.

[P06] Aave Labs, asset technical assessment, October 23, 2026. AAPLc on Base, in the Aave risk-assessments thread. https://governance.aave.com/t/coinbase-b20-equities-on-base-assessments/25690/4 . Supports observations about AAPLc token mechanics, reported oracle update rules, issuer access controls and historical feed-publication gaps. The assessment is dated after the filmed example and does not reproduce Paige's specific transaction or rates.

[D01] WYCF calculation, derived from E01. $26,600 × 5.6% = $1,489.60 annualized; $26,600 × 1.27% = $337.82; difference = $1,151.78. These are conditional computations, not a confirmed realized trading outcome.

Research methodology and limitations

The historical figures in this research were reported during the October 9, 2026 recording. WYCF has reproduced the arithmetic shown in [D01], but has not independently reconstructed the example account from an onchain position snapshot. This distinction applies to collateral and debt balances, position-level risk parameters, destination investment allocations and historical lending or borrowing rates. Readers conducting investment due diligence should verify those records independently and examine instrument rights, market liquidity and the applicable oracle and liquidation rules. Documentation of a protocol mechanism does not establish that a particular trade was executed or that a stated return was realized.

Where Yield Comes From: Financial mechanisms, risk and evidence behind capital moving onchain. This research accompanies WYCF Masterclass Season 2, Episode 01 featuring Paige Horinek of Base. For the episode and related materials, visit https://wycf.show/.

Scope: Educational financial research. This file is neither investment advice nor a quote of currently available yields or market parameters. Product eligibility varies by jurisdiction.